Friday 6 November 2026 Export MANE’s income statement to Excel — free account

Veradermics Incorporated

MANE Healthcare Biotechnology

Insider buying

138.19 9.59 +7.46%

Follow MANE

Alert me

Market cap: $5.4B
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Valuation Filings

Veradermics Incorporated 8-K filed Mar 30, 2026

Period ended Mar 30, 2026 · Filed Mar 30, 2026 · accepted 8:44 AM ET · Document on sec.gov · Filing index

2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

Nothing in this filing raised a red flag, and we have no summary of it. The items it reports are listed above; the document itself is on sec.gov.

Read the filing on sec.gov The press release